Semanteon Capital Management LP Boosts Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Semanteon Capital Management LP increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 115.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 66,776 shares of the pharmacy operator’s stock after purchasing an additional 35,774 shares during the quarter. Semanteon Capital Management LP’s holdings in Walgreens Boots Alliance were worth $623,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp grew its holdings in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after buying an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after buying an additional 2,185,950 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after buying an additional 817,762 shares during the period. Bank of New York Mellon Corp grew its holdings in Walgreens Boots Alliance by 9.6% in the 4th quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock valued at $50,684,000 after buying an additional 478,061 shares during the period. Finally, Amundi grew its holdings in Walgreens Boots Alliance by 70.3% in the 4th quarter. Amundi now owns 4,455,720 shares of the pharmacy operator’s stock valued at $41,082,000 after buying an additional 1,839,045 shares during the period. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on the company. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Royal Bank of Canada lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Truist Financial reduced their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Finally, StockNews.com began coverage on Walgreens Boots Alliance in a research note on Tuesday. They issued a “hold” rating on the stock. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $11.10 on Friday. The business’s 50 day moving average is $10.96 and its two-hundred day moving average is $9.82. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The firm has a market cap of $9.59 billion, a price-to-earnings ratio of -1.08, a PEG ratio of 1.31 and a beta of 0.62. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the company posted $0.66 EPS. Walgreens Boots Alliance’s quarterly revenue was up 7.6% on a year-over-year basis. Analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.